News
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a ...
Prednisolone and antihistamine tablets provided similar levels of relief for patients with allergic rhinitis during tree pollen season, according to a study published in Clinical and Translational ...
2d
GlobalData on MSNJ&J eyes prostate cancer label expansion for AkeegaJ&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.
J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...
Patients who are on blood thinners are advised to try and avoid nicks of the skin as the medication reduces the ability for ...
Prednisolone acetate ophthalmic suspension 1% is a sterile, topical anti-inflammatory agent for ophthalmic use and is ...
Amneal plans to launch the product in the third quarter of 2025. According to IQVIA, U.S. annual sales for prednisolone acetate ophthalmic suspension for the 12 months ended April 2025 were about ...
When ibuprofen is taken alongside blood thinners it increases a risk of bleeding and so ibuprofen should be avoided. If ...
Croup usually starts with a mild, cold-like illness, characterised by a runny nose, mild fever (around 38.5 °C), and, ...
Johnson & Johnson has announced the submission of an extension of indication application to the European Medicines Agency (EMA) seeking approval of Akeega (niraparib/abiraterone acetate) with ...
Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...
A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results